2015
DOI: 10.1111/bcpt.12484
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Gabapentin, an Analgesic Used Against Cancer‐Associated Neuropathic Pain: Effects on Prostate Cancer Progression in anIn VivoRat Model

Abstract: A major problem associated with clinical management of cancer is controlling the accompanying pain, and various analgesics are in common use for this purpose. Recent evidence suggests that some of the targets of analgesics, such as ion channels and receptors, may also be involved in the cancer process, thereby raising the possibility that such use of some analgesics may impact upon cancer itself. The main aim of this study was to determine whether gabapentin, a common adjuvant analgesic in current use against … Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
15
5
4
2

Citation Types

0
17
0
0

Year Published

Range
2015
2015
2025
2025

Publication Types

Select...
22

Relationship

2
20

Authors

Journals

citations

Cited by 22 publications

(17 citation statements)
references

References 68 publications

0
17
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…In vivo, local injection of the highly specific VGSC blocker, tetrodotoxin (TTX), into primary tumours significantly reduced metastases to lungs and prolonged survival 14 . In contrast, proliferative activity in vitro and in vivo was not affected by VGSC blockage consistent with the notion that primary tumorigenesis (ie proliferation) and metastasis (ie invasion) are controlled differently, even partially independently 15‐18 . Finally, quantitative analysis of “receiver operator characteristics” (ROC) in human biopsy tissues suggested that Nav1.7 mRNA expression had sufficient selectivity and specificity to serve as an effective biomarker of PCa 6 …”
Section: Introduction
mentioning
confidence: 78%